ResearcherOkayama UniversityNo recent work listed
Shinichiro Muro
Matched on ORCID iD 0000-0001-7626-4342; OpenAlex author ID A5072769282. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2015: 1 paper · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper
Papers 6
- Plasma KRAS mutations predict the early recurrence after surgical resection of pancreatic cancer. Co-author DOI 10.1080/15384047.2021.1980312↗
- Evaluation of Local Recurrence of Pancreatic Cancer by KRAS Mutation Analysis Using Washes from Endoscopic Ultrasound-Guided Fine-Needle Aspiration. Co-author DOI 10.1007/s10620-019-06006-6↗
- Diagnostic Ability of Convex-Arrayed Endoscopic Ultrasonography for Major Vascular Invasion in Pancreatic Cancer. Co-author DOI 10.5946/ce.2018.163↗
- Efficacy and safety of chemotherapy after endoscopic double stenting for malignant duodenal and biliary obstructions in patients with advanced pancreatic cance… Co-author DOI 10.1186/s12876-018-0886-8↗
- Utility of serum DNA as a marker for KRAS mutations in pancreatic cancer tissue. Co-author DOI 10.1016/j.pan.2016.12.011↗
- Serum anti-60S ribosomal protein L29 antibody as a novel prognostic marker for unresectable pancreatic cancer. Co-author DOI 10.1159/000371545↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hironari Kato · 6 shared papers, 2015–2021 · strength 0.49
- Paper Plasma KRAS mutations predict the early recurrence after surgical resection of pancreatic cancer. DOI 10.1080/15384047.2021.1980312↗
- Paper Evaluation of Local Recurrence of Pancreatic Cancer by KRAS Mutation Analysis Using Washes from Endoscopic Ultrasound-G… DOI 10.1007/s10620-019-06006-6↗
- Paper Diagnostic Ability of Convex-Arrayed Endoscopic Ultrasonography for Major Vascular Invasion in Pancreatic Cancer. DOI 10.5946/ce.2018.163↗
- Shigeru Horiguchi · 5 shared papers, 2017–2021 · strength 0.42
- Paper Plasma KRAS mutations predict the early recurrence after surgical resection of pancreatic cancer. DOI 10.1080/15384047.2021.1980312↗
- Paper Evaluation of Local Recurrence of Pancreatic Cancer by KRAS Mutation Analysis Using Washes from Endoscopic Ultrasound-G… DOI 10.1007/s10620-019-06006-6↗
- Paper Diagnostic Ability of Convex-Arrayed Endoscopic Ultrasonography for Major Vascular Invasion in Pancreatic Cancer. DOI 10.5946/ce.2018.163↗
- Daisuke Uchida · 5 shared papers, 2017–2021 · strength 0.42
- Paper Plasma KRAS mutations predict the early recurrence after surgical resection of pancreatic cancer. DOI 10.1080/15384047.2021.1980312↗
- Paper Evaluation of Local Recurrence of Pancreatic Cancer by KRAS Mutation Analysis Using Washes from Endoscopic Ultrasound-G… DOI 10.1007/s10620-019-06006-6↗
- Paper Diagnostic Ability of Convex-Arrayed Endoscopic Ultrasonography for Major Vascular Invasion in Pancreatic Cancer. DOI 10.5946/ce.2018.163↗
- Kazuyuki Matsumoto · 5 shared papers, 2017–2021 · strength 0.42
- Paper Plasma KRAS mutations predict the early recurrence after surgical resection of pancreatic cancer. DOI 10.1080/15384047.2021.1980312↗
- Paper Evaluation of Local Recurrence of Pancreatic Cancer by KRAS Mutation Analysis Using Washes from Endoscopic Ultrasound-G… DOI 10.1007/s10620-019-06006-6↗
- Paper Diagnostic Ability of Convex-Arrayed Endoscopic Ultrasonography for Major Vascular Invasion in Pancreatic Cancer. DOI 10.5946/ce.2018.163↗
- Soichiro Ako · 3 shared papers, 2017–2021 · strength 0.26
- Paper Plasma KRAS mutations predict the early recurrence after surgical resection of pancreatic cancer. DOI 10.1080/15384047.2021.1980312↗
- Paper Evaluation of Local Recurrence of Pancreatic Cancer by KRAS Mutation Analysis Using Washes from Endoscopic Ultrasound-G… DOI 10.1007/s10620-019-06006-6↗
- Paper Utility of serum DNA as a marker for KRAS mutations in pancreatic cancer tissue. DOI 10.1016/j.pan.2016.12.011↗
- Kazuhiro Nouso · 3 shared papers, 2017–2021 · strength 0.26
- Paper Plasma KRAS mutations predict the early recurrence after surgical resection of pancreatic cancer. DOI 10.1080/15384047.2021.1980312↗
- Paper Evaluation of Local Recurrence of Pancreatic Cancer by KRAS Mutation Analysis Using Washes from Endoscopic Ultrasound-G… DOI 10.1007/s10620-019-06006-6↗
- Paper Utility of serum DNA as a marker for KRAS mutations in pancreatic cancer tissue. DOI 10.1016/j.pan.2016.12.011↗
- Hideaki Kinugasa · 3 shared papers, 2017–2021 · strength 0.26
- Paper Plasma KRAS mutations predict the early recurrence after surgical resection of pancreatic cancer. DOI 10.1080/15384047.2021.1980312↗
- Paper Evaluation of Local Recurrence of Pancreatic Cancer by KRAS Mutation Analysis Using Washes from Endoscopic Ultrasound-G… DOI 10.1007/s10620-019-06006-6↗
- Paper Utility of serum DNA as a marker for KRAS mutations in pancreatic cancer tissue. DOI 10.1016/j.pan.2016.12.011↗
- Koichiro Tsutsumi · 3 shared papers, 2015–2018 · strength 0.20
- Paper Efficacy and safety of chemotherapy after endoscopic double stenting for malignant duodenal and biliary obstructions in… DOI 10.1186/s12876-018-0886-8↗
- Paper Serum anti-60S ribosomal protein L29 antibody as a novel prognostic marker for unresectable pancreatic cancer. DOI 10.1159/000371545↗
- Paper Utility of serum DNA as a marker for KRAS mutations in pancreatic cancer tissue. DOI 10.1016/j.pan.2016.12.011↗
- Hiroyuki Okada · 2 shared papers, 2019–2020 · strength 0.19
- Paper Evaluation of Local Recurrence of Pancreatic Cancer by KRAS Mutation Analysis Using Washes from Endoscopic Ultrasound-G… DOI 10.1007/s10620-019-06006-6↗
- Paper Diagnostic Ability of Convex-Arrayed Endoscopic Ultrasonography for Major Vascular Invasion in Pancreatic Cancer. DOI 10.5946/ce.2018.163↗
- Hiroyuki Okada · 2 shared papers, 2018–2021 · strength 0.18
- Yuzo Umeda · 1 shared paper, 2021 · strength 0.10
- Hiroyuki Terasawa · 1 shared paper, 2021 · strength 0.10
- Ryuichi Yoshida · 1 shared paper, 2021 · strength 0.10
- Yuki Fujii · 1 shared paper, 2019 · strength 0.09
- Kazuhide Yamamoto · 1 shared paper, 2015 · strength 0.06
- Hiroyuki M. OKADA · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.